BioTelemetry Executive and Leadership Team

Randy Thurman, the Chairman, President & Chief Executive Officer at BioTelemetry, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of cardiac monitoring services and mobile blood-glucose technology, Thurman ensures alignment between clinical research requirements and commercial objectives. This leadership role involves managing complex stakeholder relationships and driving expansion across North American healthcare markets. By optimizing internal resource allocation, Randy Thurman strengthens the competitive position of the company within the medical manufacturing sector. The Chairman, President & Chief Executive Officer maintains rigorous standards for operational excellence while fostering innovation in diagnostic imaging. Through consistent focus on scalable growth, Thurman secures the financial health of the enterprise. This executive leadership ensures that all departments remain synchronized with the mission of providing high-quality, remote patient monitoring solutions to clinical partners and medical facilities throughout the region.

James Sweeny, the Chairman & Chief Executive Officer at BioTelemetry, governs the board and executes high-level strategic initiatives to maintain market leadership. Focusing on the expansion of centralized medical imaging services, Sweeny drives the development of original equipment manufacturing capabilities to meet evolving industry demands. This role requires constant collaboration with the executive team to refine the service delivery model for clinical research sectors. By prioritizing technological advancement, James Sweeny ensures that the company remains at the forefront of the digital health landscape. The Chairman & Chief Executive Officer oversees the implementation of enterprise-wide policies that enhance operational efficiency and service reliability. Through strategic oversight of global market trends, Sweeny positions the organization to capture new opportunities in remote diagnostics. This leadership function supports the broader goal of delivering precise, actionable data to healthcare providers, ultimately improving the standard of care for patients requiring continuous cardiac monitoring.

Winton Brown, the President & Principal at BioTelemetry, manages the day-to-day operational execution and business development initiatives. Overseeing the manufacturing and distribution of medical equipment, Brown ensures that supply chain logistics align with the needs of the healthcare sector. This leadership role involves optimizing internal processes to increase efficiency and reduce time-to-market for new diagnostic technologies. By driving regional growth strategies, Winton Brown expands the footprint of the company within the clinical research market. The President & Principal coordinates with department heads to ensure that operational output meets the high quality standards expected by medical partners. Through the implementation of lean manufacturing principles, Brown improves the overall productivity of the organization. This executive function supports the long-term sustainability of the business by maintaining a focus on operational agility and service excellence, ensuring that the company continues to deliver critical monitoring solutions to healthcare providers.

Polina Voloshko, the Chief Medical Officer at BioTelemetry, directs the clinical strategy and medical integrity of all diagnostic monitoring services. Overseeing the validation of cardiac and blood-glucose data, Voloshko ensures that every product meets stringent regulatory and medical standards. This leadership role involves guiding the research and development teams to incorporate clinical insights into new medical device designs. By bridging the gap between complex medical requirements and engineering execution, Polina Voloshko drives the development of high-accuracy diagnostic tools. The Chief Medical Officer collaborates with clinical research organizations to refine protocols for medical imaging and patient monitoring. Through the application of deep medical expertise, Voloshko enhances the reliability of the diagnostic output provided to healthcare professionals. This executive function ensures that the company maintains a reputation for clinical excellence, supporting the overall mission of providing life-saving data to the medical community across diverse patient populations.